The Development of Pro-Apoptotic Cancer Therapeutics

Author(s): Noha I. Ziedan, Hachemi Kadri, Andrew D. Westwell

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 8 , Issue 7 , 2008

Become EABM
Become Reviewer


Resistance to apoptosis is one of the fundamental hallmarks of cancer. Recently, the selective induction of apoptosis in cancer cells has emerged as an exciting possibility for the development of future selective cancer therapy. This review will summarise the development of the major classes of small molecule “pro-apoptotic” antitumour agents.

Keywords: Pro-apoptotic cancer therapy, selective antitumour agents, apoptosis, small molecules, mitochondria-targeting, Xlinked inhibitor of apoptosis (XIAP), B-cell lymphoma 2 (Bcl-2), aerobic glycolysis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [711 - 718]
Pages: 8
DOI: 10.2174/138955708784567430
Price: $65

Article Metrics

PDF: 2